Jeffery Gryn
Hematology & Oncology · Dunmore, PANPI 1427033455
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.4% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in PA, where the typical reported total is $1,277.
Across 37 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$66
- E.r. Squibb & Sons, L.L.C.$37
- Bayer$35
- Astellas Pharma US Inc$34
- Johnson & Johnson$28
- Genentech USA, Inc.$28
- plus $361 from 21 others
What the payments were for
- Food & beverage$56295%
- Education$275%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 4 | $66 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Bayer | 2 | $35 |
| Astellas Pharma US Inc | 2 | $34 |
| Johnson & Johnson(2 entities) | 2 | $28 |
| Genentech USA, Inc. | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Rigel Pharmaceuticals, Inc. | 2 | $25 |
| EMD Serono, Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Nevro Corp. | 1 | $21 |
| Bristol Myers Squibb | 1 | $19 |
| Eisai Inc. | 1 | $17 |
| Array Biopharma Inc | 1 | $17 |
| Exelixis Inc. | 1 | $17 |
| Merck | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $16 |
| Novartis | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
| Seagen Inc. | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
| Sanofi | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $11 |
| Clovis Oncology, Inc. | 1 | $11 |
How this compares
$589 in reported general payments places this provider in the 35th percentile of 682 hematology & oncology providers in Pennsylvania.
Other hematology & oncology in Dunmore
- Salman FazalPittsburgh$2.3M
- Cyrus KhanPittsburgh$1.9M
- Usama GergisAllentown$1.2M
- Kit LuHarrisburg$810K
- Henry FungPhiladelphia$730K
- Alexander BarsoukPittsburgh$674K
- Abdalla SholiWilliamsport$576K
- Charu AggarwalPhiladelphia$541K
- Tracey EvansEast Norriton$500K
- Corey LangerPhiladelphia$492K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.